Why HCA Healthcare, Inc.’s (HCA) Stock Is Up 8.71%
As of Wednesday, November 04, HCA Healthcare, Inc.’s HCA share price has surged by 8.71%, which has investors questioning if this is right time to sell.Jenna Brashear
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Jenna Brashear
Rosalio Madrigal
Tudor Pop
Michael Rose
| Share Statistics | HCA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $106,008.8 | $2,064.9 | 97% |
|
| Shares Out (Mil) | 217.2 | 79.7 | 77% |
|
| Institutional Ownership | 97.7% | 85.9% | 75% |
|
| Float (Mil) | 136.7 | 58.8 | 66% |
|
| Beta | 1.11 | 0.74 | 66% |
|
| Avg Daily Volume (000s) | 1,781 | 684 | 78% |
|
| Price Change (52-week) |
7.6% | 82.2% | 57% |
|
| Growth | HCA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 8.0% | 10.4% | 51% |
|
| Net Income (5yr) | 12.6% | (1.1%) | 59% |
|
| EPS (5yr) | 21.0% | 1.2% | 70 |
|
| Dividends (5yr) | 46.3% | 0.0% | 94% |
|
| Cash Flow (5yr) | (25.3%) | (17.3%) | 25% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 18 | 17 | 22 | |
| Current EPS | $8.203 | $30.164 | $31.285 | |
| Month Ago EPS | $8.048 | $29.489 | $32.016 | |
| # Rev Up | 2 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | $7.977 | $29.559 | $32.159 | |
| Year/Year Chg | 12.8% | 6.5% | 22.8% | |
| Financials | HCA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $78,701 | $1,532 | 98% |
|
| Net Income (TTM) (Mil) | $6,776 | $31 | 97% |
|
| EPS (TTM) | $30.611 | $0.300 | 99% |
|
| Operating Cash Flow (TTM) (Mil) | $11,169 | $168 | 98% |
|
| Net Cash Flow (TTM) (Mil) | ($89) | $2 | 16% |
|
| Long-Term Debt (Q1) (Mil) | $44,333 | $417 | 98% |
|
| Enterprise Value (Q1) (Mil) | $153,731 | $2,409 | 98% |
|
| Valuation | HCA | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.94 | na |
|
| P/E | 16.8 | 27.5 | 44% |
|
| Dividend Yield | 0.6% | 0.0% | 63% |
|
| PEG (5yr hist) | 0.8 | 1.1 | 40% |
|
| Ratios | HCA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 42.8% | 27.2% | 53% |
|
| Net Margin | 8.6% | 1.3% | 58% |
|
| ROA | 11.0% | 2.2% | 88% |
|
| ROE | (101.0%) | 6.8% | 9% |
|
| Liabilities to Assets | 107.2% | 61.5% | 95% |
|
| F-Score | 7 | 5 | 82% |
|
Passing Stock Screens
As of 11/5/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 6.9% |
| +/- S&P 500: | -0.5 |
| Performance Since Inception: | 13.5% |
| +/- S&P 500: | +6.1 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors